263 related articles for article (PubMed ID: 27042241)
1. Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer.
Kristiansen S; Nielsen D; Sölétormos G
Clin Epigenetics; 2016; 8():35. PubMed ID: 27042241
[TBL] [Abstract][Full Text] [Related]
2. Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer.
Kristiansen S; Jørgensen LM; Hansen MH; Nielsen D; Sölétormos G
Biomed Res Int; 2015; 2015():986024. PubMed ID: 26339655
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
7. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
Bondurant AE; Huang Z; Whitaker RS; Simel LR; Berchuck A; Murphy SK
Gynecol Oncol; 2011 Dec; 123(3):581-7. PubMed ID: 21955482
[TBL] [Abstract][Full Text] [Related]
9. Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.
van Zogchel LMJ; Lak NSM; Verhagen OJHM; Tissoudali A; Gussmalla Nuru M; Gelineau NU; Zappeij-Kannengieter L; Javadi A; Zijtregtop EAM; Merks JHM; van den Heuvel-Eibrink M; Schouten-van Meeteren AYN; Stutterheim J; van der Schoot CE; Tytgat GAM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820594
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry.
Yazici H; Terry MB; Cho YH; Senie RT; Liao Y; Andrulis I; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2723-5. PubMed ID: 19755643
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation patterns of RAR-β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions.
Kougioumtsidou N; Vavoulidis E; Nasioutziki M; Symeonidou M; Pratilas GC; Mareti E; Petousis S; Chatzikyriakidou A; Grimbizis G; Theodoridis T; Miliaras D; Dinas K; Zepiridis L
Diagn Cytopathol; 2021 Jan; 49(1):153-164. PubMed ID: 32530576
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
13. Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.
Gupta V; Agarwal P; Deshpande P
Ann Diagn Pathol; 2021 Jun; 52():151722. PubMed ID: 33621744
[TBL] [Abstract][Full Text] [Related]
14. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.
Van der Auwera I; Elst HJ; Van Laere SJ; Maes H; Huget P; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2009 Apr; 100(8):1277-86. PubMed ID: 19367284
[TBL] [Abstract][Full Text] [Related]
15. Methylation status and protein expression of RASSF1A in breast cancer patients.
Hagrass HA; Pasha HF; Shaheen MA; Abdel Bary EH; Kassem R
Mol Biol Rep; 2014 Jan; 41(1):57-65. PubMed ID: 24253900
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Kioulafa M; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2009 Jul; 42(10-11):970-5. PubMed ID: 19374895
[TBL] [Abstract][Full Text] [Related]
18. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
Kloten V; Becker B; Winner K; Schrauder MG; Fasching PA; Anzeneder T; Veeck J; Hartmann A; Knüchel R; Dahl E
Breast Cancer Res; 2013 Jan; 15(1):R4. PubMed ID: 23320751
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
